UB Paderborn / Katalog / Suche / in CDI

Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415

PloS one, 2021-04, Vol.16 (4), p.e0249123-e0249123

2021

Volltextzugriff (PDF)

Antiparkinson Drug Use and Adherence in Medicare Part D Beneficiaries With Parkinson’s Disease

Clinical therapeutics, 2013-10, Vol.35 (10), p.1513-1525.e1

2013

Volltextzugriff (PDF)

Antiparkinson Drug Adherence and Its Association with Health Care Utilization and Economic Outcomes in a Medicare Part D Population

Value in health, 2014-03, Vol.17 (2), p.196-204

2014

Volltextzugriff (PDF)

The DTC microbiome testing industry needs more regulation

Science (American Association for the Advancement of Science), 2024-03, Vol.383 (6688), p.1176-1179

2024

Volltextzugriff (PDF)

The Impact of Regulatory Policies on the Future of Fecal Microbiota Transplantation

The Journal of law, medicine & ethics, 2019-12, Vol.47 (4), p.482-504

2019

Volltextzugriff (PDF)

A proposed definition of microbiota transplantation for regulatory purposes

Gut microbes, 2017-05, Vol.8 (3), p.208-213

2017

Volltextzugriff (PDF)

Policy implications of drug importation

Clinical therapeutics, 2007-12, Vol.29 (12), p.2758-2767

2007

Volltextzugriff (PDF)

Relationships between antiparkinson medication nonadherence, regimen modifications, and healthcare utilization and expenditures

Parkinsonism & related disorders, 2015-01, Vol.21 (1), p.36-41

2015

Volltextzugriff (PDF)

Methodological Comparison of Mapping the Expanded Prostate Cancer Index Composite to EuroQoL-5D-3L Using Cross-Sectional and Longitudinal Data: Secondary Analysis of NRG/RTOG 0415

JCO clinical cancer informatics, 2022-06, Vol.6, p.e2100188

2022

Volltextzugriff (PDF)

White Paper: Value of Specialty Certification in Pharmacy

Journal of the American Pharmacists Association, 2004-09, Vol.44 (5), p.612-620

2004

Volltextzugriff (PDF)

Navigating Through a Complex and Inconsistent Regulatory Framework: Section 503B of the Federal Food Drug and Cosmetic Act Outsourcing Facilities Engaged in Clinical Investigation

Therapeutic innovation & regulatory science, 2016-05, Vol.50 (3), p.270-278

2016

Volltextzugriff (PDF)

Racial/ethnic and age disparities in chemotherapy selection for colorectal cancer

The American journal of managed care, 2010-07, Vol.16 (7), p.515-522

2010

Volltextzugriff (PDF)

Variability and growth in spending for outpatient specialty pharmaceuticals

Health affairs (Millwood, Va.), 2005-07, Vol.24 (4), p.1117

2005

Volltextzugriff (PDF)

Formulary tier placement for commonly prescribed branded drugs: benchmarking and creation of a preferred placement index

The American journal of managed care, 2007-06, Vol.13 (6 Pt 2), p.377-384

2007

Volltextzugriff (PDF)

The impact of pipeline drugs on drug spending growth

Health affairs (Millwood, Va.), 2001-09, Vol.20 (5), p.210

2001

Volltextzugriff (PDF)

The effect of managed care on prescription drug costs and benefits

PharmacoEconomics, 1999-02, Vol.15 (2), p.129-140

1999

Volltextzugriff (PDF)

The Development of Direct-to-Consumer Prescription Drug Advertising Regulation

Food and drug law journal, 2002-01, Vol.57 (3), p.423-443

2002

Volltextzugriff (PDF)

The Future of Stool Banks: A Premature Death?

Food and drug law journal, 2021-01, Vol.76 (4), p.522-578

2021

Volltextzugriff (PDF)

ISPOR Code of Ethics for Researchers Background Article—Report of the ISPOR Task Force on Code of Ethics for Researchers

Value in health, 2004-03, Vol.7 (2), p.111-117

2004

Volltextzugriff (PDF)

Criteria to Request Pharmacoeconomic Data and Data Sources for Hospital Formulary Decisions

Therapeutic innovation & regulatory science, 2001, Vol.35 (1), p.231-240

2001

Volltextzugriff (PDF)

Payer types associated with antipsychotic polypharmacy in an ambulatory care setting

Journal of pharmaceutical health services research, 2012-09, Vol.3 (3), p.149-155

2012

Volltextzugriff (PDF)

Government, Big Pharma, and the People: A Century of Dis-Ease

Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 2021, Vol.24 (10), p.1400

Palumbo, Francis B

2021

Volltextzugriff (PDF)

Pharmacy-Related Compliance Issues Facing Pharmacies and Pharmacists in 2021

Journal of Health Care Compliance, 2021-01, Vol.23 (1), p.31-75

2021

Volltextzugriff (PDF)

Access to pharmaceuticals in the post-Medicare Part D era

Journal of pharmaceutical health services research, 2010-03, Vol.1 (1), p.9-14

2010

Volltextzugriff (PDF)

Incidence and Characteristics of Antibiotic Use in Aged Nursing Home Patients

Journal of the American Geriatrics Society (JAGS), 1991-10, Vol.39 (10), p.963-972

1991

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415

Antiparkinson Drug Use and Adherence in Medicare Part D Beneficiaries With Parkinson’s Disease

Antiparkinson Drug Adherence and Its Association with Health Care Utilization and Economic Outcomes in a Medicare Part D Population

The DTC microbiome testing industry needs more regulation

The Impact of Regulatory Policies on the Future of Fecal Microbiota Transplantation

A proposed definition of microbiota transplantation for regulatory purposes

Policy implications of drug importation

Relationships between antiparkinson medication nonadherence, regimen modifications, and healthcare utilization and expenditures

Methodological Comparison of Mapping the Expanded Prostate Cancer Index Composite to EuroQoL-5D-3L Using Cross-Sectional and Longitudinal Data: Secondary Analysis of NRG/RTOG 0415

White Paper: Value of Specialty Certification in Pharmacy

Navigating Through a Complex and Inconsistent Regulatory Framework: Section 503B of the Federal Food Drug and Cosmetic Act Outsourcing Facilities Engaged in Clinical Investigation

Racial/ethnic and age disparities in chemotherapy selection for colorectal cancer

Variability and growth in spending for outpatient specialty pharmaceuticals

Formulary tier placement for commonly prescribed branded drugs: benchmarking and creation of a preferred placement index

The impact of pipeline drugs on drug spending growth

The effect of managed care on prescription drug costs and benefits

The Development of Direct-to-Consumer Prescription Drug Advertising Regulation

The Future of Stool Banks: A Premature Death?

ISPOR Code of Ethics for Researchers Background Article—Report of the ISPOR Task Force on Code of Ethics for Researchers

Criteria to Request Pharmacoeconomic Data and Data Sources for Hospital Formulary Decisions

Payer types associated with antipsychotic polypharmacy in an ambulatory care setting

Government, Big Pharma, and the People: A Century of Dis-Ease

Pharmacy-Related Compliance Issues Facing Pharmacies and Pharmacists in 2021

Access to pharmaceuticals in the post-Medicare Part D era

Incidence and Characteristics of Antibiotic Use in Aged Nursing Home Patients

Suchergebnisse filtern